Search Results

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Glucosylceramide synthase inhibition in combination with aripiprazole sensitizes hepatocellular cancer cells to sorafenib and doxorubicin by Jennemann, Richard (Author) , Volz, Martina (Author) , Frias Soler, Roberto Carlos (Author) , Schulze, Almut (Author) , Richter, Karsten (Author) , Kaden, Sylvia (Author) , Sandhoff, Roger (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Management of locally advanced or metastatic combined hepatocellular cholangiocarcinoma by Zhao, Jemmy (Author) , Stephan-Falkenau, Susann (Author) , Schuler, Markus (Author) , Arndt, Börge (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients by Weinmann, Arndt (Author) , Schulze-Bergkamen, Henning (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4

    Small molecules alter VEGFR and PTEN expression in HPV-positive and -negative SCC: new hope for targeted-therapy by Aderhold, Marc Christoph (Author) , Lammert, Anne (Author) , Umbreit, Claudia (Author) , Birk, Richard (Author) , Sommer, Ulrich (Author) , Hörmann, Karl (Author) , Schultz, Johannes D. (Author) ,


    Get full text
    Article (Journal) Online Resource
  5. 5

    Targeting mTOR and AREG with Everolimus, Sunitinib and Sorafenib in HPV-positive and -negative SCC by Aderhold, Marc Christoph (Author) , Lammert, Anne (Author) , Umbreit, Claudia (Author) , Birk, Richard (Author) , Weiß, Christel (Author) , Sommer, Ulrich (Author) , Hörmann, Karl (Author) , Schultz, Johannes D. (Author) ,


    Get full text
    Article (Journal) Online Resource
  6. 6

    Sorafenib in patients with refractory or recurrent multiple myeloma by Yordanova, Anna (Author) , Hose, Dirk (Author) , Neben, Kai (Author) , Witzens-Harig, Mathias (Author) , Raab, Marc-Steffen (Author) , Goldschmidt, Hartmut (Author) ,


    Get full text
    Article (Journal) Online Resource
  7. 7

    Treatment of hepatocellular carcinoma with sorafenib: focus on special populations and adverse event by Schott, Eckart (Author) , Ebert, Matthias (Author) , Trojanek, Joanna B. (Author) ,


    Get full text
    Article (Journal) Online Resource
  8. 8

    Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial by Egberts, Friederike (Author) , Gutzmer, R. (Author) , Ugurel, S. (Author) , Becker, J. C. (Author) , Trefzer, U. (Author) , Degen, A. (Author) , Schenck, F. (Author) , Frey, L. (Author) , Wilhelm, T. (Author) , Hassel, Jessica C. (Author) , Schadendorf, D. (Author) , Livingstone, E. (Author) , Mauch, C. (Author) , Garbe, C. (Author) , Berking, C. (Author) , Rass, K. (Author) , Mohr, P. (Author) , Kaehler, K. C. (Author) , Weichenthal, M. (Author) , Hauschild, A. (Author) ,


    Get full text
    Article (Journal) Online Resource